IQVIA Holdings Inc. Overview
Pro stress-test →IQVIA is a global provider of clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries. The company offers a range of solutions powered by IQVIA Connected Intelligence, which includes high-quality health data, Healthcare-grade AI, advanced analytics, and technology infrastructure. IQVIA serves as a critical infrastructure partner for drug development and commercialization across the pharmaceutical, biotech, medical device, and healthcare sectors.
Strategic Profile
Pro stress-test →With approximately 88,000 employees in over 100 countries, IQVIA is dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide. IQVIA was named to the Fortune World's Most Admired Companies List, ranked No. 1 in its sector for the fifth consecutive year in January 2026. The company maintains market leadership through its integrated suite of services spanning research & development, real-world evidence generation, commercial analytics, and contract sales solutions.
Competitive Landscape
Pro stress-test →IQVIA operates in the CRO and healthcare analytics market alongside competitors including Syneos Health, Medidata, Labcorp, and Charles River Laboratories. IQVIA holds an estimated 17.7% market share in the Clinical Trial Data Management Services industry, its largest segment. The company differentiates through its integrated platform combining data, AI, and domain expertise across the full drug lifecycle.
Industry Context
IQVIA Holdings Inc. operates in Contract Research Organization (CRO) and Healthcare Intelligence Services.
Key facts
Founded: 1982 · Headquarters: Durham, NC · Employees: 88,000 · Revenue: $16.3B · Market cap: $30B